Medical Device Submissions: Why Integration Across Disciplines Determines Success

Medical Device Submissions: Why Integration Across Disciplines Determines Success Preparing a robust and compliant medical device submission file has become increasingly complex. Regulatory expectations continue to evolve, technologies are becoming more innovative, and notified bodies are placing greater emphasis on internal consistency and cross-disciplinary alignment. Over the past year, we have seen first-hand how an […]
Designing your venture to cross the gap

Designing your venture to cross the gap How value–payment misalignment shapes design, clinical evidence, partnerships, and scale in MedTech Previously, we explored the three main ways (as well as two niche plays) medical device companies can close the business case for their buyers. In this article, we build on that discussion and examine what those mechanisms […]
Why “Who Pays?” Is the First Strategic Choice in MedTech

Why “Who Pays?” Is the First Strategic Choice in MedTech How choosing who ultimately pays for your innovation shapes funding options, evidence required, and changes to succeed. Even the most innovative medical devices can fail, not because they don’t work, but because no one is able or willing to pay for them. In healthcare, the […]
Use of clinical data no longer mandatory in clinical evaluation under EU-MDR proposal?

Use of clinical data no longer mandatory in clinical evaluation under EU-MDR proposal? One of the most consequential changes introduced by the EU Medical Device Regulation (EU-MDR) was the near-universal requirement to rely on clinical data as part of the clinical evaluation. The definition of clinical data was deliberately narrow and, in many cases, effectively […]
Potential major changes ahead for the EU AI Act and MDR

Potential major changes ahead for the EU AI Act and MDR Over the past month, two separate proposals have emerged from Brussels that have the potential to resolve the growing tension between the new EU AI Act and the existing Medical Device Regulation (MDR) for medtech companies. Background and status of the AI Act In […]
Business Milestones that Matter: Maximizing MedTech Startup Success

In early-stage medtech, milestone-based funding is the norm. Therefore, it’s crucial to create ongoing value to sustain progress without excessive dilution. This requires the right milestones for each phase of the company. Milestones should be achievable with the available funding while clearly demonstrating increases in business value. The more you can prove the company’s worth […]
Is Breakthrough Worth It? The EU–US Perspective Every MedTech Founder Should Understand

Not all innovation deserves the same attention or the same investment. Some devices make care slightly better; a few fundamentally change what is possible. Breakthrough designation is meant to distinguish between the two. Yet many MedTech founders treat it as a regulatory checkbox rather than the strategic lever it can be. In reality, breakthrough status shapes how evidence is […]
Don’t worry about the sample size in your study. 30 patients will just do it, right?

“Thirty patients should be enough, right?” – If you’ve ever discussed a clinical investigation for your MedTech innovation, chances are you’ve heard this magic number. It’s the comforting figure that seems to make complex clinical statistics feel manageable — and the budget less intimidating. But while 30 might sound like a good start, it’s often more myth than method.
“But We Review Everything…” — Why AI-Generated QMS Content Still Slips Through

“That’s why AI isn’t really contributing anything to our QMS processes. We review and validate all the output anyway.” This was a recent response I received to a post about AI tool validation. And on the surface, it makes sense: an LLM produces human-readable text, so a human can simply check it. Right? No real […]